rs4646421
Variant summary
The NM_001319217.2(CYP1A1):c.-29-725C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene CYP1A1 is a tumor suppressor gene (CancerMine: 1 TSG, 1 oncogene citations). The gene CYP1A1 is a known oncogene (CancerMine: 1 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.215 (AC=32,708) in the gnomAD database across 152,078 control chromosomes, including 4,844 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.395. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001319217.2 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B1High frequency in general population | GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.395 — exceeds 1% threshold (B1 applied) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_001319217.2. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CYP1A1 | MANE Select | c.-29-725C>T | intron | Intron 1 of 6 | Prot: NP_001306146.1 | |
CYP1A1 | c.-26-728C>T | intron | Intron 1 of 6 | Prot: NP_000490.1 | ||
CYP1A1 | c.-29-725C>T | intron | Intron 1 of 5 | Prot: NP_001306145.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CYP1A1 | TSL:1MANE Select | c.-29-725C>T | intron | Intron 1 of 6 | Prot: ENSP00000369050.3 UniProt: | |
CYP1A1 | TSL:1 | c.-26-728C>T | intron | Intron 1 of 6 | Prot: ENSP00000378488.2 UniProt: | |
CYP1A1 | TSL:1 | c.-29-725C>T | intron | Intron 1 of 6 | Prot: ENSP00000456585.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | AF: 0.215 | AC:32628 | Hom:4823 | AN:151960 | Cov:31 |
GnomAD4 genome | AF: 0.215 | AC:32708 | Hom:4844 | AN:152078 | Cov:31 |
TOPMed (Bravo) | AF: 0.236 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.145 | AC:45174 | Hom:4868 | AN:310600 | |
Local & regional cohorts 10 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.226 | AC:530 | Hom:74 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.409 | ||||
Denmark Genome | AF: 0.110 | AC:33 | AN:300 | ||
GenomeAsia100K | AF: 0.419 | AC:1452 | AN:3478 | ||
Korea4K (4,157 Koreans) | AF: 0.384 | AC:2775 | AN:7232 | ||
Qatari Genome | AF: 0.142 | AC:25 | AN:176 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.366 | AC:44822 | Hom:8280 | AN:122618 | |
Turkish Variome | AF: 0.155 | AC:239 | Hom:23 | AN:1546 | |
UK10K | AF: 0.106 | AC:805 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.416 | AC:3729 | Hom:755 | AN:8960 | |
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 11 | |
BayesDel_noAF | Benign | -0.78 | |
CADD | Benign | 4.9 | |
DANN | Benign | 0.68 | |
GPN-Star LLR | N/A | -0.36 | |
GPN-Star score | N/A | 0.36 | |
Mutation Taster | N/A | 100/0 | polymorphism (auto) |
PhyloP100 | Benign | -0.27 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.